Published in CMAJ on July 10, 2001
Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol (2001) 4.05
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother (2004) 2.36
Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol (2002) 2.19
Antimicrobial resistance in Canada. CMAJ (2002) 1.81
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother (2007) 1.72
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences. Can J Infect Dis Med Microbiol (2007) 1.28
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. Antimicrob Agents Chemother (2009) 1.22
Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis (2008) 1.11
Interpretation of MRSASelect screening agar at 24 hours of incubation. J Clin Microbiol (2009) 1.08
Community-acquired methicillin-resistant Staphylococcus aureus: Getting over it. Can J Infect Dis Med Microbiol (2005) 1.05
Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study. Can Vet J (2009) 1.04
Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus, Finland, 1997-2004. BMC Infect Dis (2007) 1.01
Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago. Ann Clin Microbiol Antimicrob (2006) 0.99
Genetics 101: detecting mutations in human genes. CMAJ (2002) 0.98
Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr Infect Dis Rep (2003) 0.96
A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients. Pediatr Surg Int (2006) 0.86
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. Can J Infect Dis (2004) 0.85
A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres. Can J Infect Dis (2003) 0.84
Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008. Antimicrob Agents Chemother (2010) 0.83
Methicillin-resistant Staphylococcus aureus in First Nations communities in Canada. Paediatr Child Health (2005) 0.83
Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol (2010) 0.83
Transmission of endemic ST22-MRSA-IV on four acute hospital wards investigated using a combination of spa, dru and pulsed-field gel electrophoresis typing. Eur J Clin Microbiol Infect Dis (2012) 0.81
Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients. Can J Infect Dis (2002) 0.81
Antimicrobial resistance - Judicious use is the key. Can J Infect Dis Med Microbiol (2004) 0.77
Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009. Can J Infect Dis Med Microbiol (2015) 0.77
Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open (2014) 0.77
An assessment of linezolid utilization in selected canadian provinces. Can J Infect Dis Med Microbiol (2006) 0.76
Antimicrobial resistance: A continuing Canadian tale. Can J Infect Dis (2002) 0.75
[Not Available]. Paediatr Child Health (2005) 0.75
Stopping short the spread of methicillin-resistant Staphylococcus aureus. CMAJ (2001) 0.75
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release. Antimicrob Agents Chemother (2002) 0.75
Antimicrobial resistance in Canada: An update on activities of the Canadian Committee on Antibiotic Resistance. Can J Infect Dis (2001) 0.75
Physical Plant Design and Engineering Controls to Reduce Hospital-acquired Infections. Can J Infect Dis Med Microbiol (2006) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (1997) 18.24
Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA (1998) 15.66
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol (1991) 8.77
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol (1995) 8.36
Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol (1992) 5.98
Vancomycin-resistant enterococcal infections. N Engl J Med (2000) 5.51
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 5.46
Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis (1994) 5.28
A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16) J Hosp Infect (1995) 4.10
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group. J Infect Dis (1998) 3.94
Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol (1994) 3.27
Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis (1999) 3.06
Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol (1999) 2.69
Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65
A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1999) 2.53
The international spread of methicillin-resistant Staphylococcus aureus. J Hosp Infect (1987) 2.46
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust (1995) 2.04
The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol (1991) 1.99
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic methicillin-resistant Staphylococcus aureus. J Infect Dis (2000) 1.78
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1995) 1.64
Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (1998) 1.57
A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can J Infect Dis (1990) 1.33
Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis (1999) 1.28
The Canadian Nosocomial Infection Surveillance Program: results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can Commun Dis Rep (1997) 1.23
Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg (1998) 1.17
Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol (1998) 1.11
Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control (1988) 1.03
Methicillin resistant Staphylococcus aureus: identification of a community outbreak by monitoring of hospital isolates. Can J Public Health (1988) 0.99
Epidemiology of methicillin-resistant Staphylococcus aureus in three Canadian tertiary-care centers. Infect Control Hosp Epidemiol (1998) 0.99
Clonal diversity of methicillin-resistant Staphylococcus aureus in an acute-care institution. Infect Control Hosp Epidemiol (1992) 0.94
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Submarine thermal sprirngs on the galapagos rift. Science (1979) 5.18
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol (2008) 3.13
Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes (2001) 3.03
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Prostaglandins. Annu Rev Biochem (1975) 2.09
Improved experimental limit on the electric dipole moment of the neutron. Phys Rev Lett (2006) 1.96
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med (2006) 1.91
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol (1995) 1.90
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol (2000) 1.86
Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics (1999) 1.85
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol (1995) 1.79
Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol (2000) 1.78
Comparison of molecular methods for typing Vibrio parahaemolyticus. J Clin Microbiol (1999) 1.70
Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med (2001) 1.70
Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother (1994) 1.69
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol (2006) 1.69
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation (1999) 1.67
Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med (1999) 1.66
Sudden death in individuals in hobble restraints during paramedic transport. Ann Emerg Med (1995) 1.62
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob Agents Chemother (1989) 1.61
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS (1996) 1.59
Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis. J Clin Microbiol (1988) 1.58
Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis (1999) 1.57
Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis (2005) 1.54
The demand for private medical insurance in the UK: a cohort analysis. Econ J (London) (2001) 1.53
Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS (2004) 1.52
Perceptual adjustment to highly compressed speech: effects of talker and rate changes. J Exp Psychol Hum Percept Perform (1997) 1.51
An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital. Vet Microbiol (2005) 1.50
Percent body fat and bone mass in healthy Canadian females 10 to 19 years of age. Bone (2000) 1.47
Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol (2008) 1.47
Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother (2012) 1.45
Depressive mood and adolescent illicit drug use: a longitudinal analysis. J Genet Psychol (1977) 1.45
Direct measurements of membrane unstirred layers. J Physiol (1970) 1.45
Colonoscopy screening compliance and outcomes in patients with Lynch syndrome. Colorectal Dis (2015) 1.40
Counsellors in general practice. Br J Gen Pract (2000) 1.40
Comparative analysis of the VP3 gene of divergent strains of the rotaviruses simian SA11 and bovine Nebraska calf diarrhea virus. J Virol (1988) 1.39
Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect (2007) 1.39
Adherence to antibiotic guidelines for pneumonia in chronic-care facilities in Ontario. Clin Invest Med (2001) 1.38
A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals. J Virol (2001) 1.37
Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun (1999) 1.36
Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis (2006) 1.34
Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis (1997) 1.34
Influenza A outbreak in a nursing home: the value of early diagnosis and the use of amantadine hydrochloride. Can J Infect Control (1994) 1.34
Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis (2001) 1.33
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother (2002) 1.30
Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J (2001) 1.30
Intermediate filaments: possible functions as cytoskeletal connecting links between the nucleus and the cell surface. Ann N Y Acad Sci (1985) 1.30
Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis (1999) 1.28
Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol (2000) 1.27
The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J (1998) 1.26
Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol (2010) 1.26
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol (2005) 1.25
Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis (2001) 1.23
The Canadian Nosocomial Infection Surveillance Program: results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can Commun Dis Rep (1997) 1.23
Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group. J Clin Microbiol (1992) 1.21
VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies. Virology (1989) 1.20
Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis (1999) 1.20
A minimal avian retroviral packaging sequence has a complex structure. J Virol (1998) 1.20
Outbreaks of multi-drug resistant Escherichia coli in long-term care facilities in the Durham, York and Toronto regions of Ontario, 2000-2002. Can Commun Dis Rep (2002) 1.16
A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2001) 1.13
Effect of applying the Honan intraocular pressure reducer before cataract surgery. Am J Ophthalmol (1985) 1.13
Molecular typing of methicillin and gentamicin resistant Staphylococcus aureus in Dublin. Eur J Clin Microbiol (1986) 1.13
Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation (1994) 1.12
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia. Antimicrob Agents Chemother (1995) 1.12
Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol (1980) 1.11
Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology (2002) 1.11
Sympathetic denervation and the triphosphoinositide effect in the iris smooth muscle: a biochemical method for the determination of alpha-adrenergic receptor denervation supersensitivity. J Neurochem (1979) 1.10
Influenza and pneumococcal vaccination and tuberculin skin testing programs in long-term care facilities: where do we stand? Infect Control Hosp Epidemiol (1995) 1.10
Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol (2001) 1.10